| scholarly article | Q13442814 |
| P2093 | author name string | Derek Gordon | |
| Stephen J Finch | |||
| Michael Nothnagel | |||
| Jürg Ott | |||
| P433 | issue | 1 | |
| P921 | main subject | single-nucleotide polymorphism | Q501128 |
| P304 | page(s) | 22-33 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Human Heredity | Q15755116 |
| P1476 | title | Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms | |
| P478 | volume | 54 |
| Q30334349 | "Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. |
| Q35050878 | A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women |
| Q36090843 | A comprehensive literature review of haplotyping software and methods for use with unrelated individuals |
| Q33235034 | A detailed Hapmap of the Sitosterolemia locus spanning 69 kb; differences between Caucasians and African-Americans |
| Q44850340 | A new expectation-maximization statistical test for case-control association studies considering rare variants obtained by high-throughput sequencing |
| Q81007884 | A single nucleotide polymorphism (A --> G) in intron 3 of IFNgamma gene is associated with asthma |
| Q35978582 | A survey of current software for genetic power calculations |
| Q36587679 | A systematic review of the quality of genetic association studies in human sepsis |
| Q54709158 | A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease. |
| Q33900568 | ALG: automated genotype calling of Luminex assays |
| Q35839417 | African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity |
| Q24680494 | Analysis of KLF transcription factor family gene variants in type 2 diabetes |
| Q34078200 | Approximate and exact tests of Hardy-Weinberg equilibrium using uncertain genotypes |
| Q33255336 | Are molecular haplotypes worth the time and expense? A cost-effective method for applying molecular haplotypes |
| Q34614279 | Assessing the impact of differential genotyping errors on rare variant tests of association |
| Q35546078 | Assessing the impact of non-differential genotyping errors on rare variant tests of association |
| Q33519737 | Assessing the utility of whole-genome amplified serum DNA for array-based high throughput genotyping |
| Q33547739 | Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes |
| Q54610492 | Association between dopamine receptor D1 A-48G polymorphism and methamphetamine abuse. |
| Q33281836 | Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians |
| Q48966036 | Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population. |
| Q51748901 | Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population. |
| Q42927243 | Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population |
| Q95811798 | Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes |
| Q36408718 | Association of markers at chromosome 15q14 in Chinese patients with moderate to high myopia |
| Q45151190 | Association of tryptophan hydroxylase gene polymorphism with depression, anxiety and comorbid depression and anxiety in a population-based sample of postpartum Taiwanese women |
| Q46086323 | Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. |
| Q34916745 | Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls |
| Q61443061 | Associations between SLC16A11 variants and diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) |
| Q35019839 | Case-control association analysis of dopamine receptor polymorphisms in alcohol dependence: a pilot study in Indian males |
| Q38010012 | Challenges in reproducibility of genetic association studies: lessons learned from the obesity field |
| Q33232748 | Characteristics of replicated single-nucleotide polymorphism genotypes from COGA: Affymetrix and Center for Inherited Disease Research |
| Q33242098 | Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. |
| Q33428547 | Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians |
| Q53510530 | Comparison of identical single nucleotide polymorphisms genotyped by the GeneChip Targeted Genotyping 25K, Affymetrix 500K and Illumina 550K platforms. |
| Q33378466 | Computing power and sample size for case-control association studies with copy number polymorphism: application of mixture-based likelihood ratio test |
| Q36619654 | Computing power in case-control association studies through the use of quadratic approximations: application to meta-statistics |
| Q37586665 | DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis |
| Q37115887 | Definition of phenotype |
| Q33844431 | Detection of Mendelian consistent genotyping errors in pedigrees |
| Q81004885 | Detection of genotyping errors and pseudo-SNPs via deviations from Hardy-Weinberg equilibrium |
| Q33197920 | Detection of genotyping errors by Hardy-Weinberg equilibrium testing. |
| Q33392518 | Deviations from hardy-weinberg equilibrium in parental and unaffected sibling genotype data |
| Q33530569 | Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study |
| Q58132466 | Effect of Genotyping Error on Type-I Error Rate of Affected Sib Pair Studies with Genotyped Parents |
| Q38438070 | Effects of differential genotyping error rate on the type I error probability of case-control studies |
| Q63440939 | Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians |
| Q24810851 | Estimating haplotype frequencies in pooled DNA samples when there is genotyping error |
| Q33369394 | Estimating the single nucleotide polymorphism genotype misclassification from routine double measurements in a large epidemiologic sample |
| Q45295046 | Estimation of genotype error rate using samples with pedigree information--an application on the GeneChip Mapping 10K array |
| Q30879655 | Evaluating the concordance between sequencing, imputation and microarray genotype calls in the GAW18 data. |
| Q37689468 | Evaluating the impact of genotype errors on rare variant tests of association |
| Q101216820 | Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits |
| Q36148601 | Factors affecting statistical power in the detection of genetic association |
| Q28943341 | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder |
| Q57405103 | Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33 |
| Q36539672 | Functional single nucleotide polymorphism-based association studies |
| Q89748027 | GWAS significance thresholds for deep phenotyping studies can depend upon minor allele frequencies and sample size |
| Q48914887 | Gender effect of catechol-O-methyltransferase Val158Met polymorphism on suicidal behavior |
| Q54560033 | Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis. |
| Q36142031 | Genetic association studies of complex neurological diseases |
| Q42788958 | Genetic polymorphisms in sex hormone metabolizing genes and drug response in women with epilepsy. |
| Q50738677 | Genetic risk variants for dyslexia on chromosome 18 in a German cohort. |
| Q46126668 | Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms |
| Q80909154 | Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism |
| Q38405233 | Genetics of Type 2 Diabetes in U.S. Hispanic/Latino Individuals: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). |
| Q48632226 | Genetics of postoperative complications following thoracic surgery. |
| Q33699542 | Genome-wide association scan of attention deficit hyperactivity disorder |
| Q37435321 | Genotyping error detection in samples of unrelated individuals without replicate genotyping |
| Q36320430 | Genotyping errors: causes, consequences and solutions |
| Q93075072 | High-quality, genome-wide SNP genotypic data for pedigreed germplasm of the diploid outbreeding species apple, peach, and sweet cherry through a common workflow |
| Q54643242 | IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. |
| Q36723300 | IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-American infants |
| Q80866747 | IL-7Ralpha and multiple sclerosis risk |
| Q30440265 | Impact of genotyping errors on the type I error rate and the power of haplotype-based association methods |
| Q37514398 | Impact of measurement error on testing genetic association with quantitative traits. |
| Q34289324 | Improving the power of genetic association tests with imperfect phenotype derived from electronic medical records |
| Q33602996 | In vitro vs in silico detected SNPs for the development of a genotyping array: what can we learn from a non-model species? |
| Q33459421 | Incorporating duplicate genotype data into linear trend tests of genetic association: methods and cost-effectiveness |
| Q51976718 | Incorporating individual error rate into association test of unmatched case-control design. |
| Q33290992 | Incorporation of genetic model parameters for cost-effective designs of genetic association studies using DNA pooling |
| Q36748282 | Increased presence of oxidized low-density lipoprotein in the left ventricular blood of subjects with cardiovascular disease. |
| Q33787119 | Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure |
| Q51976715 | Issues in association analysis: error control in case-control association studies for disease gene discovery. |
| Q30814821 | LRTae: improving statistical power for genetic association with case/control data when phenotype and/or genotype misclassification errors are present |
| Q41351582 | Lack of association between ADRA2B-4825 gene insertion/deletion polymorphism and migraine in Chinese Han population. |
| Q52626885 | Linkage Disequilibrium Estimation in Low Coverage High-Throughput Sequencing Data. |
| Q33356619 | Linkage disequilibrium-based quality control for large-scale genetic studies |
| Q33417954 | Missing call bias in high-throughput genotyping |
| Q38387616 | Novel exon 1 progranulin gene variant in Alzheimer's disease. |
| Q34743434 | Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response |
| Q51514163 | On averaging power for genetic association and linkage studies. |
| Q33486490 | On quality control measures in genome-wide association studies: a test to assess the genotyping quality of individual probands in family-based association studies and an application to the HapMap data |
| Q31020644 | Optimal genotype determination in highly multiplexed SNP data |
| Q33720521 | Optimal two-stage design for case-control association analysis incorporating genotyping errors |
| Q33918200 | Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis |
| Q34169804 | Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy |
| Q45031032 | Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis. |
| Q42213908 | Power analysis for genome-wide association studies |
| Q36668489 | Power and sample size calculations for SNP association studies with censored time-to-event outcomes |
| Q47369948 | Power and sample size calculations for genetic case/control studies using gene-centric SNP maps: application to human chromosomes 6, 21, and 22 in three populations |
| Q24805056 | Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies |
| Q44672078 | Power-based, phase-informed selection of single nucleotide polymorphisms for disease association screens |
| Q89455840 | Prediction of schizophrenia using MAOA-uVNTR polymorphism: A case-control study |
| Q53376534 | Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease. |
| Q63502642 | Pyrosequencing?-based SNP allele frequency estimation in DNA pools |
| Q45301810 | Quantifying bias due to allele misclassification in case-control studies of haplotypes |
| Q47386037 | Quantifying the percent increase in minimum sample size for SNP genotyping errors in genetic model-based association studies |
| Q40164355 | R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. |
| Q44347586 | Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. |
| Q79449868 | Repeated measurement sampling in genetic association analysis with genotyping errors |
| Q41114330 | Reproducibility of Genotypes as Measured by the Affymetrix GeneChip® 100K Human Mapping Array Set. |
| Q39881833 | SCA8 repeat expansion: large CTA/CTG repeat alleles in neurological disorders and functional implications |
| Q36345804 | Sample size and statistical power calculation in genetic association studies. |
| Q36834152 | Searching for genes underlying susceptibility to osteoporotic fracture: current progress and future prospect |
| Q36430788 | Simultaneously correcting for population stratification and for genotyping error in case-control association studies |
| Q28755468 | Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology |
| Q37319565 | Smarter clustering methods for SNP genotype calling |
| Q92284587 | Statistical power in genome-wide association studies and quantitative trait locus mapping |
| Q46830153 | Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients |
| Q33443394 | Testing Hardy-Weinberg equilibrium and homogeneity of Hardy-Weinberg disequilibrium using complex survey data |
| Q51906202 | Testing for linkage and association across the dihydrolipoyl dehydrogenase gene region with Alzheimer's disease in three sample populations. |
| Q51828785 | The Genetics of Obsessive-Compulsive Disorder. |
| Q34498146 | The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons |
| Q37090601 | The complex genetics of multiple sclerosis: pitfalls and prospects |
| Q37337266 | The cost effectiveness of duplicate genotyping for testing genetic association |
| Q51929001 | The effects of SNP genotyping errors on the power of the Cochran-Armitage linear trend test for case/control association studies. |
| Q31032793 | The impact of data quality on the identification of complex disease genes: experience from the Family Blood Pressure Program |
| Q37027403 | The impact of genotype calling errors on family-based studies |
| Q51922860 | The impact of genotype misclassification errors on the power to detect a gene-environment interaction using cox proportional hazards modeling. |
| Q51945247 | The impact of missing and erroneous genotypes on tagging SNP selection and power of subsequent association tests. |
| Q43236375 | The interleukin-6, serotonin transporter, and monoamine oxidase A genes and endurance performance during the South African Ironman Triathlon |
| Q46678805 | The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population |
| Q33260566 | The merits of testing Hardy-Weinberg equilibrium in the analysis of unmatched case-control data: a cautionary note |
| Q58864945 | The norepinephrine transporter gene is a candidate gene for panic disorder |
| Q46642951 | The polymorphisms of protein-tyrosine phosphatase receptor-type delta gene and its association with pediatric asthma in the Taiwanese population |
| Q37417890 | The relationship between imputation error and statistical power in genetic association studies in diverse populations |
| Q51564245 | The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. |
| Q42555104 | Using both cases and controls for testing hardy-weinberg proportions in a genetic association study |
| Q52004489 | What SNP genotyping errors are most costly for genetic association studies? |
| Q57943305 | What makes a good genetic association study? |
| Q36854711 | beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. |
| Q53315769 | rs5848 variant of progranulin gene is a risk of Alzheimer's disease in the Taiwanese population. |
Search more.